SECUADO is a Transdermal Film, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Noven Therapeutics, Llc. The primary component is Asenapine.
| Product ID | 68968-0174_584854cb-d9a5-44e0-adaa-50ebbad1c6e7 | 
| NDC | 68968-0174 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | SECUADO | 
| Generic Name | Asenapine | 
| Dosage Form | Film, Extended Release | 
| Route of Administration | TRANSDERMAL | 
| Marketing Start Date | 2020-02-12 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA212268 | 
| Labeler Name | Noven Therapeutics, LLC | 
| Substance Name | ASENAPINE | 
| Active Ingredient Strength | 8 mg/d | 
| Pharm Classes | Atypical Antipsychotic [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2020-02-12 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA212268 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-02-12 | 
| Ingredient | Strength | 
|---|---|
| ASENAPINE | 7.6 mg/d | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 68968-0172 | SECUADO | ASENAPINE | 
| 68968-0173 | SECUADO | ASENAPINE | 
| 68968-0174 | SECUADO | ASENAPINE | 
| 42794-016 | ASENAPINE | ASENAPINE | 
| 42794-017 | ASENAPINE | ASENAPINE | 
| 46708-198 | Asenapine | Asenapine | 
| 46708-199 | Asenapine | Asenapine | 
| 46708-544 | Asenapine | Asenapine | 
| 62332-198 | Asenapine | Asenapine | 
| 62332-199 | Asenapine | Asenapine | 
| 62332-544 | Asenapine | Asenapine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  SECUADO  87659437  5646398 Live/Registered | HISAMITSU PHARMACEUTICAL CO., INC. 2017-10-25 |